Jun 08, 2026
979:958
For every 958 shares held, investors received 979. The price per share adjusted from $1.27 to $1.24.
The split itself did not change the total investment value.
IRLAB Therapeutics AB Class A (STO:IRLAB_A) operates in the Pharmaceuticals: major industry.
IRLAB Therapeutics AB Class A company overviewIRLAB Therapeutics AB Class A's most recent stock split was on June 8, 2026. It was a 979-for-958 forward split, so shareholders received 979 shares for every 958 they held.
IRLAB Therapeutics AB Class A (STO:IRLAB_A) has split its stock 4 times: a 5-for-1 split on May 28, 2019, a 288-for-283 split on February 6, 2020, a 161-for-152 split on June 30, 2025, and a 979-for-958 split on June 8, 2026.
IRLAB Therapeutics AB Class A has split its stock 4 times. This history records 4 forward splits between May 28, 2019 and June 8, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In IRLAB Therapeutics AB Class A's 979-for-958 split on June 8, 2026, every 958 shares became 979 shares.
IRLAB Therapeutics AB Class A has not announced a new split in our records. Its most recent split was on June 8, 2026, less than a year ago. Companies announce splits in advance, and any new STO:IRLAB_A split will appear on this page.
Already premium?